Herein, we demonstrate that a limitation of BRAF inhibitors when used either alone or in combination with EGFR inhibitors, is that they fail to effectively induce apoptosis in BRAFV600E CRC cell lines. The gene discussed is BRAF; the disease is colorectal carcinoma.